QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Completion of BayMedica Acquisition
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has finalized the acquisition of BayMedica Inc., a private company based in the U.S. specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector. INM had announced the acquisition earlier. According to the announcement, the acquisition provides capabilities and resources to accelerate InMed’s commercial initiatives, including the development and unveiling of several new cannabinoids products in the consumer health and wellness sector. The combined technologies include synthetic biology, chemical synthesis and IntegraSyn(TM), a patented enzymatic biotransformation. The company noted that, with…